Human Genome ultimately rebuffed a $2.6 billion offer by biopharmaceutical giant GlaxoSmithKline Plc, saying it was too low – though it has put itself on the market. Catalyst agreed to be acquired by a larger Illinois competitor for $4.4 billion.
Shares of Human Genome Sciences doubled in Thursday morning trading on news it received a $2.6 billion cash offer to acquire the company from a major bio pharmaceutical company, which it rejected as too low.
Baltimore's Millennial Media Inc., one of the largest companies in the fast-growing mobile advertising industry, said it would launch its public offering on Thursday, with expectations of selling $132.6 million worth of shares on its first day on the New York Stock Exchange.
Constellation Energy Group, Baltimore's last Fortune 500 company, also settled a federal investigation into market manipulation as Chicago-based Exelon Corp. closed its $7.9 billion takeover on Monday.
Fourteen of the 19 companies in the Baltimore region that paid their CEOs at least $1 million last year reported increases in that compensation in 2010, according to a Baltimore Sun analysis. The increases largely reflected improved performance by the companies.